The 3.5-Year Mortality Impact Of Drugs In Secondary Prevention Of Myocardial Infarction In Real-Life (Interim Analysis Of The Eole Cohort)
Value Health
.
2014 Nov;17(7):A476.
doi: 10.1016/j.jval.2014.08.1366.
Epub 2014 Oct 26.
Authors
C Droz
1
,
C Dureau
2
,
D Thomas
3
,
N Danchin
4
,
J Tricoire
5
,
J Benichou
6
,
F Paillard
7
,
S Hercberg
8
,
I Sibon
9
,
F Rouanet
9
,
S Rambelomanana
2
,
H Maizi
2
,
M A Bernard
2
,
P Blin
2
,
N Moore
10
Affiliations
1
INSERM CIC Bordeaux CIC 1401, Univ. Bordeaux, INSERM U657, Bordeaux, France.
2
INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France.
3
Hôpital Pitié Salpétrière, Paris, France.
4
Hôpital Européen Georges Pompidou, Paris, France.
5
Clinique Ambroise Paré, Toulouse, France.
6
CHU de Rouen, INSERM U657, Rouen, France.
7
CHU de Pontchaillou, Rennes, France.
8
INSERM U557, Bobigny, France.
9
CHU de Bordeaux, Bordeaux, France.
10
INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, INSERM U657, CHU Bordeaux, Bordeaux, France.
PMID:
27201378
DOI:
10.1016/j.jval.2014.08.1366
No abstract available